Skip to main content

Central labs

Articles  —  1 June Jun 2026

Q&A with Dr. Laura Crawford, PhD, DABT, RAC-Drugs

Read More about Q&A with Dr. Laura Crawford, PhD, DABT, RAC-Drugs
Articles  —  1 June Jun 2026

Inside preclinical CVMD innovation: A Q&A with Dr. Laura Crawford on integration strategies for advancing cardio‑kidney‑metabolic therapies

Read More about Inside preclinical CVMD innovation: A Q&A with Dr. Laura Crawford on integration strategies for advancing cardio‑kidney‑metabolic therapies
Articles  —  29 May May 2026

Evolving drug trends: June 2026 report

Read More about Evolving drug trends: June 2026 report
Articles  —  27 May May 2026

On-demand webinar

Read More about On-demand webinar
Articles  —  27 May May 2026

On-demand webinar Solve trial complexity with earlier, patient-centered laboratory engagement strategies

Read More about On-demand webinar Solve trial complexity with earlier, patient-centered laboratory engagement strategies
Articles  —  15 May May 2026

On-demand webinar Cardiometabolic Complexity & Successful Clinical Trials

Read More about On-demand webinar Cardiometabolic Complexity & Successful Clinical Trials
Articles  —  17 April Apr 2026

Cardiometabolic clinical trials: Interconnected science and scalable operations

Read More about Cardiometabolic clinical trials: Interconnected science and scalable operations
Articles  —  13 March Mar 2026

Advancing cardiometabolic therapy development in an era of complexity

Read More about Advancing cardiometabolic therapy development in an era of complexity
Articles  —  20 November Nov 2025

FDA’s Plausible Mechanism Pathway: Accelerating Personalized Medicine

Read More about FDA’s Plausible Mechanism Pathway: Accelerating Personalized Medicine
Articles  —  3 June Jun 2025

Getting the most out of limited samples

Read More about Getting the most out of limited samples
Articles  —  20 May May 2025

The Future of the Central Lab: Perspectives from Industry Leaders

Read More about The Future of the Central Lab: Perspectives from Industry Leaders
Articles  —  10 April Apr 2025

Enabling gene therapy access: Labcorp's first cell-based companion diagnostic (CDx)

Read More about Enabling gene therapy access: Labcorp's first cell-based companion diagnostic (CDx)
Articles  —  17 May May 2024

Leveraging global laboratory scale to deliver critical patient test results on time

Read More about Leveraging global laboratory scale to deliver critical patient test results on time
Articles  —  8 April Apr 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials

Read More about Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials
Articles  —  4 January Jan 2024

Labcorp to open new kit production innovation base in Suzhou, China

Read More about Labcorp to open new kit production innovation base in Suzhou, China
Articles  —  14 December Dec 2023

Centralized multiple myeloma service delivers on a global scale

Read More about Centralized multiple myeloma service delivers on a global scale
Articles  —  14 December Dec 2023

Minimal Residual Disease by Flow Cytometry: Latest Insights on Validation

Read More about Minimal Residual Disease by Flow Cytometry: Latest Insights on Validation
Articles  —  6 December Dec 2023

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Read More about Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay
Articles  —  16 November Nov 2023

Cell and gene therapy answers: Assessing the critical quality attributes, challenges and importance of CMC

Read More about Cell and gene therapy answers: Assessing the critical quality attributes, challenges and importance of CMC
Articles  —  13 September Sep 2023

Labcorp expanding bioanalytical service offering in the Asia-Pacific region with an integrated laboratory in Singapore

Read More about Labcorp expanding bioanalytical service offering in the Asia-Pacific region with an integrated laboratory in Singapore
Articles  —  19 July Jul 2023

Top considerations for developing a biomarker solution and CDx strategy

Read More about Top considerations for developing a biomarker solution and CDx strategy
Articles  —  24 April Apr 2023

What does a central lab do? Four core services

Read More about What does a central lab do? Four core services
Articles  —  19 April Apr 2023

Alcohol-related liver disease: Inherent challenges and strategies for successful clinical trial conduct

Read More about Alcohol-related liver disease: Inherent challenges and strategies for successful clinical trial conduct
Articles  —  27 January Jan 2023

Biomarker Q&A: The landscape and outlook for precision medicine in neurology

Read More about Biomarker Q&A: The landscape and outlook for precision medicine in neurology